Role of dopamine in the behavioural actions of nicotine related to addiction

G Di Chiara - European journal of pharmacology, 2000 - Elsevier
Experimental impairment of dopamine function by 6-hydroxydopamine lesions or by
dopamine receptor antagonists shows that dopamine is involved in nicotine's discriminative …

Genetics of dopamine receptors and drug addiction: a comprehensive review

B Le Foll, A Gallo, Y Le Strat, L Lu… - Behavioural …, 2009 - journals.lww.com
Drug dependence is a chronic, relapsing disorder in which compulsive drug-seeking and
drug-taking behaviours persist despite serious negative consequences. Addictive …

Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues

DM Ziedonis, TP George - Schizophrenia bulletin, 1997 - academic.oup.com
Nicotine use is a major public health problem that increases medical morbidity and mortality.
Nicotine's action and the pathobiology of schizophrenic disorders have common …

Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics

MW Decker, JD Brioni, AW Bannon, SP Arneric - Life sciences, 1995 - Elsevier
Although the molecular biology of neuronal nicotinic acetylcholine receptors (nAChRs)
provides evidence for multiple receptor subtypes, few selective pharmacological tools exist …

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo

CA Briggs, DJ Anderson, JD Brioni… - Pharmacology …, 1997 - Elsevier
[2, 4]-Dimethoxybenzylidene anabaseine dihydrochloride (GTS-21), a compound that
interacts with rat neuronal nicotinic acetylcholine receptors (nAChRs), was evaluated using …

Translational research in medication development for nicotine dependence

C Lerman, MG LeSage, KA Perkins… - Nature reviews Drug …, 2007 - nature.com
A major obstacle to the development of medications for nicotine dependence is the lack of
animal and human laboratory models with sufficient predictive clinical validity to support the …

Nicotine reduction revisited: science and future directions

DK Hatsukami, KA Perkins, MG LeSage… - Tobacco …, 2010 - tobaccocontrol.bmj.com
Regulation of nicotine levels in cigarettes and other tobacco products is now possible with
the passage of the Family Smoking Prevention and Tobacco Control Act (FSPTCA) in 2009 …

British American tobacco on facebook: undermining Article 13 of the global World Health Organization framework convention on tobacco control

B Freeman, S Chapman - Tobacco control, 2010 - tobaccocontrol.bmj.com
Background The World Health Organization Framework Convention on Tobacco Control
(WHO FCTC) bans all forms of tobacco advertising, promotion and sponsorship. The …

Abuse potential of non-nicotine tobacco smoke components: acetaldehyde, nornicotine, cotinine, and anabasine

AC Hoffman, SE Evans - Nicotine & Tobacco Research, 2013 - academic.oup.com
Introduction: This review identified published animal studies evaluating the possible abuse
potential of acetaldehyde, nornicotine, cotinine, and anabasine based on five commonly …

Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors

EG Pérez, C Méndez-Gálvez, BK Cassels - Natural product reports, 2012 - pubs.rsc.org
Covering: up to the end of 2011 This review covers classical and modern structural
modifications of the alkaloid, the more recent (since 2007) syntheses of cytisine and …